The MHRA has issued a Class 4 (Caution in Use) Drug Alert for Actilyse 20mg and 50mg powder and solvent for solution for injection and infusion (alteplase).
There have been an increased number of complaints where the rubber stopper has been pushed into the vial during reconstitution. This renders the vial unusable.
Users who experience this issue are asked to report to Boehringer Ingleheim Medical Information on 01344 742579 or email@example.com
Full details are available via the MHRA.